Purification of retrovirus particles using heparin affinity chromatography

  1. Get@NRC: Purification of retrovirus particles using heparin affinity chromatography (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1007/978-1-60327-248-3_1
AuthorSearch for: ; Search for: ; Search for:
Journal titleMethods in Molecular Biology
Pages111; # of pages: 11
Subjectbio; chemistry; embrane Glycoproteins; ene Therapy; enes; enetic Vectors; enetics; eparin; ethods; etroviridae; herapy; hromatography,Affinity; iral Envelope Proteins; lycoproteins; rotein; roteins; solation and purification; ucrose; Genes; Gene Therapy; therapy; Chromatography; Heparin; Sucrose; recombinant retrovirus vector; gene theraphy; purification; scaleable processes; membrane filtration; chromatography; heparain affinity chromatography
AbstractRetroviral vectors have been used as gene delivery behicles for more than two decades and continue to be the best available tool for stable and efficient transfer of therapeutic genes into various cell types. Although most gene therapy preclinical studies presently use crude or concentrated retroviral vector supernatants, purification to eliminate serum and host-derived impurities contained in these stocks will be a necessary requirement for clinical applications. Chromatography is deemed the most promising technology for large-scale purification of viral vectors. Heparin affinity chromatography offers the possibility to selectively and efficiently purify retroviruses. This chapter gives a simple, reproducible, and scaleable protocol for the purification of bioactive VSV-G pseudotyped retroviral vectors that employs membrane and chromatography technologies. The protocol can be easily adapted for the purification of different retroviral vector pseudotypes and lentiviral vectors. The purification techniques described here represent a significant improvement over the conventional sucrose density gradient methodology used for retrovirus purification and will hopefully contribute to the technological progress in the field of gene therapy.
Publication date
AffiliationNRC Biotechnology Research Institute (BRI-IRB); National Research Council Canada
Peer reviewedNo
NRC number47834
NPARC number12401005
Export citationExport as RIS
Report a correctionReport a correction
Record identifier1a0a3712-df7b-400b-9309-c80414ca9250
Record created2009-10-26
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)